Epidermal growth factor receptor status in breast cancer metastases to the central nervous system: Comparison with HER-2/neu status

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 9, 2004, Pages 974-979

  Grupka, Nichon L ^a   Lear Kaul, Kelly C ^b   Kleinschmidt DeMasters, Bette K ^a   Singh, Meenakshi ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; GEFITINIB; MONOCLONAL ANTIBODY; TRASTUZUMAB;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER LOCALIZATION; CANCER PATIENT; CENTRAL NERVOUS SYSTEM METASTASIS; CONTROLLED STUDY; DIMERIZATION; DRUG EFFICACY; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; ONCOGENE NEU; TREATMENT OUTCOME; WILD TYPE;

ADULT; BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 4444342416     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Herbst RS. Erlotinib (Tarceva): an update on the clinical trial program. Semin Oncol. 2003;30(3 suppl 7):34-46.
2. LoRusso PM. Phase I studies of ZD1839 in patients with common solid tumors. Semin Oncol. 2003;30(1 suppl 1):21-29.
3. Bunn PA Jr, Franklin W. Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer. Semin Oncol. 2002;29(5 suppl 14):38-44.
4. Morris C. The role of EGFR-directed therapy in the treatment of breast cancer. Breast Cancer Res Treat. 2002;75:S51-S55.
5. Campiglio M, Locatelli A, Olgiati C, et al. Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 ('Iressa') is independent of EGFR expression level. J Cell Physiol. 2004;198:259-268.
6. Ritter CA, Arteaga CL. The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors. Semin Oncol. 2003;30(1 suppl 1): 3-11.
7. Moscatello DK, Holgado-Madruga M, Godwin AK, et al. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res. 1995;55:5536-5539.
8. Mamot C, Drummond DC, Greiser U, et al. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Cancer Res. 2003;63:3154-3161.
9. Lear-Kaul KC, Yoon H, Kleinschmidt-DeMasters BK, McGavran L, Singh M. HER-2/neu status in breast cancer metastases to the central nervous system. Arch Pathol Lab Med. 2003;127:1451-1457.
10. Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL. Epidermal-growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet. 1987;8547:1398-1402.
11. Tsutsui S, Ohno S, Murakami S, Kataoka A, Kinoshita J, Hachitanda Y. Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer. Surgery. 2003;133:219-221.
12. Nicholson S, Sainsbury JRC, Halcrow P, Chambers P, Farndon JR, Harris AL. Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet. 1989;8631:182-185.
13. Atalay G, Cardoso F, Awada A, Piccart MJ. Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer. Ann Oncol 2003;14:1346-1363.
14. Normanno N, Campiglio M, De Luca A, et al. Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth. Ann Oncol. 2002;13:65-72.
15. Anderson NG, Ahmad T, Chan K, et al. ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression. Int J Cancer. 2001;94:774-782.
16. EGFr Kit (clone 31G7), PicTure Plus™-Polymer Detection: for immunohistostaining of epidermal growth factor receptor (EGFr) [package insert]. Catalog No. 28-8763. South San Francisco, Calif: Zymed Laboratories Inc; 2003: 1-10.
17. Spaulding DC, Spaulding BO. Epidermal growth factor receptor expression and measurement in solid tumors. Semin Oncol. 2002;29(5 suppl 14):45-54.